Throne Biotechnologies
Company profile on P2PMarketData. Throne Biotechnologies is a biotechnology company based in Paramus, NJ, founded in 2011. It has raised $199.5K through crowdfunding on StartEngine.
Throne Biotechnologies is a biotechnology company headquartered in Paramus, New Jersey, United States. Established in 2011, the company's primary focus is the development of its Stem Cell Educator therapy, a patented technology designed to provide a practical cure for type 1 diabetes, alopecia areata, and other autoimmune conditions. The therapy aims to re-educate the defective immune system through a one-time, dialysis-like treatment.
Frequently asked questions about Throne Biotechnologies
How much funding has Throne Biotechnologies raised?
Throne Biotechnologies has raised $199.5K through crowdfunding across 1 round tracked by P2PMarketData, from 102 investors.
What is Throne Biotechnologies' valuation?
Throne Biotechnologies had an indicative valuation of $120M in its 2022 funding round.
Is Throne Biotechnologies profitable?
No. Throne Biotechnologies reported a net loss of $482.2K for fiscal year 2021.
How many employees does Throne Biotechnologies have?
Throne Biotechnologies reported 5 employees for fiscal year 2021.
When was Throne Biotechnologies founded?
Throne Biotechnologies was founded in January 2011.
Where is Throne Biotechnologies based?
Throne Biotechnologies is headquartered in Paramus, New Jersey, United States, and is incorporated in Delaware, United States.
What industry is Throne Biotechnologies in?
Throne Biotechnologies operates in the Biotechnology industry within the Healthcare sector.